| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 8,728 | 7,508 | 6,653 | | Cost of Revenue | 6,963 | 6,431 | 5,990 | | | Gross Profit | 1,766 | 1,077 | 663 | | | Operating Expenses | | Research Development | 2,463 | 2,169 | 1,608 | | Selling General and Administrative | 3,783 | 3,905 | 2,855 | | Non Recurring | (1) | (2) | 1 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (4,480) | (4,995) | (3,801) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 111 | 463 | 446 | | Earnings Before Interest And Taxes | (4,369) | (4,532) | (3,355) | | Interest Expense | 33 | 41 | 47 | | Income Before Tax | (4,402) | (4,573) | (3,403) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,402) | (4,573) | (3,403) | | | Non-recurring Events | | Discontinued Operations |
-
| (13) | (29) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,402) | (4,586) | (3,431) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,402) | ($4,586) | ($3,431) |
|
1.11% Nasdaq 
Income Statement
